Needham & Company analyst Mike Matson lowered the price target on CONMED (NYSE: CNMD) to $150.00 (from $158.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE